AstraZeneca approaches Gilead about merger - Bloomberg

Jun. 07, 2020 9:14 AM ETAstraZeneca PLC (AZN), GILDAZN, GILDBy: Stephen Alpher, SA News Editor182 Comments
  • AstraZeneca (NYSE:AZN) last month informally got in touch with Gilead (NASDAQ:GILD) about a possible merger, according to the report. Terms weren't discussed, but Gilead has since reached out to advisers. Formal talks between the two, however, aren't yet underway.
  • AstraZeneca has a market cap of $140B; Gilead of $96B. Should a deal happen, it would easily surpass last year's Bristol-Myers/Celgene $74B tie-up as the largest-ever healthcare merger.

Recommended For You

Comments (182)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.